Article Information
History
- September 24, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Elodie Monchatre-Leroy1,*,
- Sandrine Lesellier2,
- Marine Wasniewski3,†,
- Evelyne Picard-Meyer3,†,
- Céline Richomme4,†,
- Franck Boué4,†,
- Sandra Lacôte5,†,
- Séverine Murri5,†,
- Coralie Pulido6,†,
- Johann Vulin5,
- Francisco J Salguero7,
- Meriadeg Ar Gouilh8,9,
- Alexandre Servat3 and
- Philippe Marianneau5
- 1Nancy laboratory for rabies and wildlife, ANSES, Malzéville, France
- 2Nancy laboratory for rabies and wildlife, ANSES, Atton experimental facility, Atton France
- 3Nancy laboratory for rabies and wildlife, ANSES, Lyssavirus Unit, Malzéville, France
- 4Nancy laboratory for rabies and wildlife, ANSES, SEEpiAS Unit, Malzéville, France
- 5Lyon laboratory, ANSES, Virology Unit, Lyon, France
- 6Lyon laboratory, ANSES, Platform of animal experiment, Lyon, France
- 7Public Health England, Porton Down, UK
- 8Groupe de Recherche sur l’Adaptation Microbienne, Normandie Université, Caen, France
- 9Service de Virologie, CHU de Caen, Caen, France
- ↵*Corresponding author: elodie.monchatre-leroy{at}anses.fr;
↵† These authors contributed equally to this work.
Posted September 24, 2020.
Hamster and ferret experimental infection with intranasal low dose of a single strain of SARS-CoV-2
